A detailed history of Vestcor Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vestcor Inc holds 21,590 shares of REGN stock, worth $16 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
21,590
Previous 20,936 3.12%
Holding current value
$16 Million
Previous $22 Million 3.14%
% of portfolio
0.72%
Previous 0.74%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1024.09 - $1201.76 $669,754 - $785,951
654 Added 3.12%
21,590 $22.7 Million
Q2 2024

Aug 13, 2024

SELL
$883.2 - $1071.19 $69,772 - $84,624
-79 Reduced 0.38%
20,936 $22 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $1 Million - $1.1 Million
-1,108 Reduced 5.01%
21,015 $20.2 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $930,215 - $1.06 Million
-1,200 Reduced 5.15%
22,123 $19.4 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $2.36 Million - $2.88 Million
-3,408 Reduced 12.75%
23,323 $19.2 Million
Q2 2023

Aug 15, 2023

BUY
$700.03 - $830.35 $2.15 Million - $2.55 Million
3,069 Added 12.97%
26,731 $19.2 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $3.68 Million - $4.47 Million
-5,406 Reduced 18.6%
23,662 $19.4 Million
Q4 2022

Feb 15, 2023

SELL
$705.89 - $766.39 $6.4 Million - $6.95 Million
-9,069 Reduced 23.78%
29,068 $21 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $924,091 - $1.17 Million
-1,610 Reduced 4.05%
38,137 $26.3 Million
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $795,655 - $1.07 Million
-1,451 Reduced 3.52%
39,747 $23.5 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $662,963 - $778,051
-1,114 Reduced 2.63%
41,198 $28.8 Million
Q4 2021

Feb 15, 2022

BUY
$543.48 - $670.97 $1.02 Million - $1.26 Million
1,885 Added 4.66%
42,312 $26.7 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $1 Million - $1.19 Million
1,743 Added 4.51%
40,427 $24.5 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $6.11 Million - $7.22 Million
12,922 Added 50.16%
38,684 $21.6 Million
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $1.26 Million - $1.55 Million
2,821 Added 12.3%
25,762 $12.2 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $517,998 - $658,442
1,083 Added 4.95%
22,941 $11.1 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $242,958 - $293,561
446 Added 2.08%
21,858 $12.2 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $9.72 Million - $12.7 Million
19,701 Added 1151.43%
21,412 $13.4 Million
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $109,594 - $161,184
326 Added 23.54%
1,711 $835,000
Q4 2019

Feb 12, 2020

BUY
$274.13 - $376.51 $379,670 - $521,466
1,385 New
1,385 $520,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.